Report Detail
Global Pruritus Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
- RnM2921712 |
- 11 February, 2019 |
- Global |
- 118 Pages |
- GIR (Global Info Research) |
- Other
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
Scope of the Report:
Skin disease is the fourth leading cause of nonfatal disease burden. Skin diseases include eczema, psoriasis, acne vulgaris, pruritus, alopecia areata, decubitus ulcer, urticaria, scabies, fungal skin diseases, impetigo, abscess, and other bacterial skin diseases, cellulitis, viral warts, molluscum contagiosum, and non-melanoma skin cancer. Among these types, fungal skin diseases and pruritus were in the top 10 most prevalent diseases worldwide in 2010. Thus pruritus therapeutics market is growing with rising prevalence of skin diseases. Moreover, patent expiration of dermatitis drugs and the introduction of new products are also responsible for the growth of pruritus therapeutics market.
The classification of Pruritus Therapeutics includes Corticosteroids, Antihistamines, Calcineurin Inhibitors and other. The proportion of Antihistamines in 2016 is about 21.6%, and the proportion of Corticosteroids is about 22.9%.
North America is the largest consumption place, with a revenue market share nearly 43.4% in 2016. Following North America, Europe is the second largest consumption place with the revenue market share of 27.3%.
The global Pruritus Therapeutics market is valued at 11300 million USD in 2018 and is expected to reach 15000 million USD by the end of 2024, growing at a CAGR of 4.9% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Pruritus Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Pruritus Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Pruritus Therapeutics market by product type and applications/end industries.
Market Segment by Companies, this report covers
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Other
Market Segment by Applications, can be divided into
External Use
Oral
Injection
Table of Contents
1 Pruritus Therapeutics Market Overview
- 1.1 Product Overview and Scope of Pruritus Therapeutics
- 1.2 Classification of Pruritus Therapeutics by Types
- 1.2.1 Global Pruritus Therapeutics Revenue Comparison by Types (2019-2024)
- 1.2.2 Global Pruritus Therapeutics Revenue Market Share by Types in 2018
- 1.2.3 Antihistamines
- 1.2.4 Corticosteroids
- 1.2.5 Calcineurin Inhibitors
- 1.2.6 Other
- 1.3 Global Pruritus Therapeutics Market by Application
- 1.3.1 Global Pruritus Therapeutics Market Size and Market Share Comparison by Applications (2014-2024)
- 1.3.2 External Use
- 1.3.3 Oral
- 1.3.4 Injection
- 1.4 Global Pruritus Therapeutics Market by Regions
- 1.4.1 Global Pruritus Therapeutics Market Size (Million USD) Comparison by Regions (2014-2024)
- 1.4.1 North America (USA, Canada and Mexico) Pruritus Therapeutics Status and Prospect (2014-2024)
- 1.4.2 Europe (Germany, France, UK, Russia and Italy) Pruritus Therapeutics Status and Prospect (2014-2024)
- 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pruritus Therapeutics Status and Prospect (2014-2024)
- 1.4.4 South America (Brazil, Argentina, Colombia) Pruritus Therapeutics Status and Prospect (2014-2024)
- 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pruritus Therapeutics Status and Prospect (2014-2024)
- 1.5 Global Market Size of Pruritus Therapeutics (2014-2024)
2 Manufacturers Profiles
- 2.1 J&J
- 2.1.1 Business Overview
- 2.1.2 Pruritus Therapeutics Type and Applications
- 2.1.2.1 Product A
- 2.1.2.2 Product B
- 2.1.3 J&J Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.2 Abbott
- 2.2.1 Business Overview
- 2.2.2 Pruritus Therapeutics Type and Applications
- 2.2.2.1 Product A
- 2.2.2.2 Product B
- 2.2.3 Abbott Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.3 Amgen
- 2.3.1 Business Overview
- 2.3.2 Pruritus Therapeutics Type and Applications
- 2.3.2.1 Product A
- 2.3.2.2 Product B
- 2.3.3 Amgen Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.4 LEO Pharma
- 2.4.1 Business Overview
- 2.4.2 Pruritus Therapeutics Type and Applications
- 2.4.2.1 Product A
- 2.4.2.2 Product B
- 2.4.3 LEO Pharma Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.5 Novartis
- 2.5.1 Business Overview
- 2.5.2 Pruritus Therapeutics Type and Applications
- 2.5.2.1 Product A
- 2.5.2.2 Product B
- 2.5.3 Novartis Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.6 Bayer
- 2.6.1 Business Overview
- 2.6.2 Pruritus Therapeutics Type and Applications
- 2.6.2.1 Product A
- 2.6.2.2 Product B
- 2.6.3 Bayer Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.7 Pfizer
- 2.7.1 Business Overview
- 2.7.2 Pruritus Therapeutics Type and Applications
- 2.7.2.1 Product A
- 2.7.2.2 Product B
- 2.7.3 Pfizer Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.8 UCB Pharma
- 2.8.1 Business Overview
- 2.8.2 Pruritus Therapeutics Type and Applications
- 2.8.2.1 Product A
- 2.8.2.2 Product B
- 2.8.3 UCB Pharma Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.9 GlaxoSmithKline
- 2.9.1 Business Overview
- 2.9.2 Pruritus Therapeutics Type and Applications
- 2.9.2.1 Product A
- 2.9.2.2 Product B
- 2.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.10 Galderma
- 2.10.1 Business Overview
- 2.10.2 Pruritus Therapeutics Type and Applications
- 2.10.2.1 Product A
- 2.10.2.2 Product B
- 2.10.3 Galderma Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
- 2.11 Huapont
- 2.11.1 Business Overview
- 2.11.2 Pruritus Therapeutics Type and Applications
- 2.11.2.1 Product A
- 2.11.2.2 Product B
- 2.11.3 Huapont Pruritus Therapeutics Revenue, Gross Margin and Market Share (2017-2018)
3 Global Pruritus Therapeutics Market Competition, by Players
- 3.1 Global Pruritus Therapeutics Revenue and Share by Players (2014-2019)
- 3.2 Market Concentration Rate
- 3.2.1 Top 5 Pruritus Therapeutics Players Market Share
- 3.2.2 Top 10 Pruritus Therapeutics Players Market Share
- 3.3 Market Competition Trend
4 Global Pruritus Therapeutics Market Size by Regions
- 4.1 Global Pruritus Therapeutics Revenue and Market Share by Regions
- 4.2 North America Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 4.3 Europe Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 4.4 Asia-Pacific Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 4.5 South America Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 4.6 Middle East and Africa Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
5 North America Pruritus Therapeutics Revenue by Countries
- 5.1 North America Pruritus Therapeutics Revenue by Countries (2014-2019)
- 5.2 USA Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 5.3 Canada Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 5.4 Mexico Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
6 Europe Pruritus Therapeutics Revenue by Countries
- 6.1 Europe Pruritus Therapeutics Revenue by Countries (2014-2019)
- 6.2 Germany Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 6.3 UK Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 6.4 France Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 6.5 Russia Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 6.6 Italy Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Pruritus Therapeutics Revenue by Countries
- 7.1 Asia-Pacific Pruritus Therapeutics Revenue by Countries (2014-2019)
- 7.2 China Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 7.3 Japan Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 7.4 Korea Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 7.5 India Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 7.6 Southeast Asia Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
8 South America Pruritus Therapeutics Revenue by Countries
- 8.1 South America Pruritus Therapeutics Revenue by Countries (2014-2019)
- 8.2 Brazil Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 8.3 Argentina Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 8.4 Colombia Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Pruritus Therapeutics by Countries
- 9.1 Middle East and Africa Pruritus Therapeutics Revenue by Countries (2014-2019)
- 9.2 Saudi Arabia Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 9.3 UAE Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 9.4 Egypt Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 9.5 Nigeria Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
- 9.6 South Africa Pruritus Therapeutics Revenue and Growth Rate (2014-2019)
10 Global Pruritus Therapeutics Market Segment by Type
- 10.1 Global Pruritus Therapeutics Revenue and Market Share by Type (2014-2019)
- 10.2 Global Pruritus Therapeutics Market Forecast by Type (2019-2024)
- 10.3 Antihistamines Revenue Growth Rate (2014-2024)
- 10.4 Corticosteroids Revenue Growth Rate (2014-2024)
- 10.5 Calcineurin Inhibitors Revenue Growth Rate (2014-2024)
- 10.6 Other Revenue Growth Rate (2014-2024)
11 Global Pruritus Therapeutics Market Segment by Application
- 11.1 Global Pruritus Therapeutics Revenue Market Share by Application (2014-2019)
- 11.2 Pruritus Therapeutics Market Forecast by Application (2019-2024)
- 11.3 External Use Revenue Growth (2014-2019)
- 11.4 Oral Revenue Growth (2014-2019)
- 11.5 Injection Revenue Growth (2014-2019)
12 Global Pruritus Therapeutics Market Size Forecast (2019-2024)
- 12.1 Global Pruritus Therapeutics Market Size Forecast (2019-2024)
- 12.2 Global Pruritus Therapeutics Market Forecast by Regions (2019-2024)
- 12.3 North America Pruritus Therapeutics Revenue Market Forecast (2019-2024)
- 12.4 Europe Pruritus Therapeutics Revenue Market Forecast (2019-2024)
- 12.5 Asia-Pacific Pruritus Therapeutics Revenue Market Forecast (2019-2024)
- 12.6 South America Pruritus Therapeutics Revenue Market Forecast (2019-2024)
- 12.7 Middle East and Africa Pruritus Therapeutics Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
Summary:
Get latest Market Research Reports on Pruritus Therapeutics . Industry analysis & Market Report on Pruritus Therapeutics is a syndicated market report, published as Global Pruritus Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Pruritus Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
